Myeloproliferative neoplasms trials in China

5 of 30 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• No phaseNot yet taking people in China
  A Multicenter, Prospective, Observational Study of Jaktinib in Newly Diagnosed Myelofibrosis

  Where

  Nantong

  Age

  18 years and over

  People

  80

  Run by

  Affiliated Hospital of Nantong University

  See details and how to joinNCT07925632
• No phaseNot yet taking people in China
  Jaktinib in Ruxolitinib-Treatment Failure Myelofibrosis: A Multicenter, Prospective, Real-World Observational Study

  Where

  Nantong

  Age

  18 years and over

  People

  80

  Run by

  Affiliated Hospital of Nantong University

  See details and how to joinNCT07925671
• No phaseTaking people
  National Longitudinal Cohort of Hematological Diseases

  Where

  Tianjin

  People

  2,300

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT04645199
• No phaseTaking people
  18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

  Where

  Hangzhou

  Age

  18 years to 80 years

  People

  57

  Run by

  First Affiliated Hospital of Zhejiang University

  See details and how to joinNCT06164561
• No phaseTaking people
  68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

  Where

  Xiamen

  Age

  18 years and over

  People

  90

  Run by

  The First Affiliated Hospital of Xiamen University

  See details and how to joinNCT06151119